# Filing Detail

Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-24-155130
Filing Date
2024-06-05
Accepted
2024-06-05 16:08:02
Documents
8

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B3 | d827839d424b3.htm | 424B3 | 1276078
2 | GRAPHIC | g827839g39e87.jpg | GRAPHIC | 107523
3 | GRAPHIC | g827839g39f89.jpg | GRAPHIC | 98906
4 | GRAPHIC | g827839g39g90.jpg | GRAPHIC | 90285
5 | GRAPHIC | g827839g39h91.jpg | GRAPHIC | 141850
6 | GRAPHIC | g827839g78y82.jpg | GRAPHIC | 100822
7 | GRAPHIC | g827839g78z86.jpg | GRAPHIC | 83721
8 | GRAPHIC | g827839g82q02.jpg | GRAPHIC | 64491
| Complete submission text file | 0001193125-24-155130.txt |  | 2197396

Mailing Address 919 WEST DILLON ROAD LOUISVILLE CO 80027
Business Address 919 WEST DILLON ROAD LOUISVILLE CO 80027 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-278881 | Film No.: 241022054
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)